Trial intelligence / Profile preview

KALOS: PT010 vs PT009 vs Symbicort in severe asthma

jRCT2031200331Phase 3Completed

Sponsor
AstraZeneca
Start
Feb 2021
Modality
Small Molecules
01

Overview

A Phase 3 trial of Breztri Aerosphere in asthma, sponsored by AstraZeneca. Started Feb 2021; status: completed.

02

Drugs

Breztri Aerosphere
03

Conditions

asthma

Beyond the preview

Go deeper on jRCT2031200331.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2031200331.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call